Skip to main content
SpringerLink
Log in

Steroid receptors and human endometrial carcinoma: studies in a nude mouse model

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

An experimental nude mouse system where human endometrial carcinomas of different histologic grade and steroid receptor characteristics can be grown and maintained under defined hormonal milieu by serial transplantation has been developed. Biologically and clinically important information on the role of steroid receptors in eliciting hormonal responses in these tumors has been obtained using this model. These results form the basis for designing and testing various treatment strategies for endometrial carcinomas of different histologic grade and receptor content.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Silverberg E: Cancer Statistics. CA 32: 18, 1982

    Google Scholar 

  2. Kelley RM, Baker WH: Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 264: 216–222, 1960

    Google Scholar 

  3. McGuire WL, Carbone PO, Vollmer EP: ‘Estrogen Receptors in Human Breast Cancer’. Raven Press, New York, 1975

    Google Scholar 

  4. Allegra JC, Lippman ME, Thompson EB, Simon R, Bartok A, Green L, Hupp KK, Do HMI, Aitken SC, Warren R: Relationship between the progesterone, androgen and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Treat Rep 62: 1281–1286, 1978

    Google Scholar 

  5. McGuire WL: ‘Hormones, Receptors and Breast Cancer’. Raven Press, New York, 1978

    Google Scholar 

  6. Mortel R, Zaino RJ, Satyaswaroop PG: Sex steroid receptors and hormonal treatment of endometrial cancer. In: Deppe G (ed) Chemotherapy of Gynecologic Cancer. Alan R Liss, Inc., N. Y., 1984, pp 125–138

    Google Scholar 

  7. Martin PM, Rolland PH, Gammere M, Serment H, Toga M: Estradiol and progesterone receptors in normal and neoplastic endometriums: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 24: 324–329, 1979

    Google Scholar 

  8. Benraad TJ, Friberg LG, Koenders AJM, Kullander S: Do estrogen and progesterone receptors in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand 59: 155–159, 1980

    Google Scholar 

  9. Creasman WT, McCartySr KS, Barton TK, McCartySr KS: Clinical correlates of estrogen and progesterone binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55: 363–370, 1980

    Google Scholar 

  10. Satyaswaroop PG, Mortel R: Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma. Cancer Res 42: 1322–1325, 1982

    Google Scholar 

  11. Mortel R, Zaino RJ, Satyaswaroop PG: Heterogeneity and progesterone receptor distribution in endometrial adenocarcinoma. Cancer 53: 113–116, 1984

    Google Scholar 

  12. Satyaswaroop PG, Zaino R, Mortel R: Human endometrial adenocarcinoma transplanted into nude mice: Growth regulation by estradiol. Science 219: 58–60, 1983

    Google Scholar 

  13. Shafie DM: Estrogen and the growth of breast cancer: New evidence suggests indirect action. Science 209: 701–702, 1980

    Google Scholar 

  14. Sirbasku DA, Benson RH: Estrogen-inducible growth factors that may act as mediators (estromedins) of estrogen-promoted tumor cell growth. In: Sato GH, Ross R (eds) Cold Spring Harbor Conference on Cell Proliferation. Cold Spring Harbor, N. Y., 1979, Vol 6, pp 477–497

  15. Sirbasku DA: Estrogen-induction of growth factors specific for hormone-responsive mannary, pituitary, and kidney tumor cells. Proc Natl Acad Sci USA 75: 3786–3790, 1978

    Google Scholar 

  16. Satyaswaroop PG, Mortel R: Endometrial carcinoma: An aberration of endometrial cell differentiation. Am J Obstet Gynecol 140: 620–623, 1981

    Google Scholar 

  17. Tseng L, Gurpide E: Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 92: 825–828, 1975

    Google Scholar 

  18. Satyaswaroop PG, Zaino RJ, Mortel R: Estrogen-like effect of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44: 4006–4010, 1984

    Google Scholar 

  19. Swenerton KD, Shaw D, White GW, et al.. Treatment of advanced endometrial carcinoma with tamoxifen, N Engl J Med 301: 105, 1979

    Google Scholar 

  20. Swenerton KD: Treatment of advanced endometrial adenocarcinoma with tamoxifen. Cancer Treat Rep 64: 805–811, 1980

    Google Scholar 

  21. Bonte J, Ide P, Billiet G, et al.: Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma. Gynecol Oncol 11: 140–161, 1981

    Google Scholar 

  22. Edmonson JH, Krook JE, Hilton JF, Long HJ, Cullinan SA, Everson LK, Malkasian GD: Ineffectiveness of Tamoxifen in Advanced Endometrial Carcinoma After Failure of Progestin Treatment. Cancer Treat Rep 70: 1019–1020, 1986

    Google Scholar 

  23. Bichon M, Bayard F: Dissociated effects of tamoxifen and oestradiol 17 on uterus and liver. J Steroid Biochem 10: 105–107, 1979

    Google Scholar 

  24. Fex G, Adielsson G, Mattson W: Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol 97: 109–113, 1981

    Google Scholar 

  25. Gallez G, Henson JC, Waelbroek C: Growth-stimulating effect of nafoxidine on rat mannary tumor after ovariectomy. Eur J Cancer 9: 699–700, 1973

    Google Scholar 

  26. Helgason S, Wilking N, Carlstrom K, Damber MG, Schoultz BV: A comparative study of the estrogenic effects of tamoxifen and 17 estradiol in postmenopausal women. J Clin Endocrinol Metab 54: 404–408, 1982

    Google Scholar 

  27. Horwitz KB, Koseki Y, McGuire WL: Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103: 1742–1751, 1978

    Google Scholar 

  28. Leavitt WW, Chen TJ, Allen TC: Regulation of progesterone receptor formation by estrogen action. Ann NY Acad Sci 286: 210–225, 1975

    Google Scholar 

  29. Legault-Poisson S, Jolivet J, Poisson R, Beretta-Piccoli M, Ban PR: Tamoxifen-induced tumor stimulation and with-drawal response. Cancer Treat Rep 63: 1839–1941, 1979

    Google Scholar 

  30. Martin L, Middleton E: Prolonged oestrogenic and mitrogenic activity of tamoxifen in the ovariectomized mouse. J Endocrinol 78: 125–129, 1978

    Google Scholar 

  31. Mortel R, Levy C, Wolff J-P, Nicholas J-C, Robel P, Baulieu E-E: Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to anticstrogen. Cancer Res 41: 1140–1147, 1981

    Google Scholar 

  32. Tsai LS, Katzenellenbogen BS: Antagonism of development and growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U23. 469 and effects on estrogen and progesterone receptors. Cancer Res 37: 1537–1543, 1977

    Google Scholar 

  33. Martin PM: Medroxyprogesterone acetate. In: Cavilli F, McGuire WL, Pannuti F, Pellegrini A, Cun GR (eds) Excerpta Medica, Switzerland, 1982, p 360

    Google Scholar 

  34. Killackey MA, Hakes TB, Pierce VK: Endometrial adenocarcinoma in breast cancer patients receiving anti-estrogens. Cancer Treat Rep 69: 237–239, 1985

    Google Scholar 

  35. Zaino RJ, Satyaswaroop PG, Mortel R: Morphology of human uterine carrier in nude mice. Arch Pathol Lab Med 108: 571–578, 1984

    Google Scholar 

  36. Zaino RJ, Satyaswaroop PG, Mortel R: Hormonal therapy of human endometrial carcinoma in a nude mouse model. Cancer Res 45: 539–541, 1985

    Google Scholar 

  37. Fluhmann CF: Squamous metaplasia in the rat uterus. Arch Pathol 59: 238–264, 1955

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, The Milton S. Hershey Medical Center, The Pennsylvania State University, P.O. Box 850, 17033, Hershey, PA, USA

    P. G. Satyaswaroop & R. Mortel

  2. Department of Pathology, The Milton S. Hershey Medical Center, The Pennsylvania State University, P.O. Box 850, 17033, Hershey, PA, USA

    R. J. Zaino

Authors
  1. P. G. Satyaswaroop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Zaino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Mortel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Satyaswaroop, P.G., Zaino, R.J. & Mortel, R. Steroid receptors and human endometrial carcinoma: studies in a nude mouse model. Cancer Metast Rev 6, 223–241 (1987). https://doi.org/10.1007/BF00144265

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144265

Key words

Search

Navigation